Current Report Filing (8-k)
November 12 2020 - 1:50PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
November
5, 2020
Date
of Report (Date of earliest event reported)
PETVIVO
HOLDINGS, INC.
(Exact
name of registrant as specified in its charter)
Nevada
|
|
000-55167
|
|
99-0363559
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
5251
Edina Industrial Blvd.
Edina,
Minnesota
|
|
55349
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
(952)
405-6216
Registrant’s
telephone number, including area code
Check
the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of each exchange on which registered
|
Common
Stock
|
|
PETV
|
|
OTCQB
|
On November 5,
2020, PetVivo Holdings, Inc. (“Company”) entered into a University Services Agreement (“Agreement”) with
Colorado State University (“CSU”) whereby CSU has agreed to conduct a double-blinded study titled “Evaluation
of the effect of intra-articular injection of a proprietary extracellular matrix for osteoarthritis-associated pain in dogs.”
This Agreement calls for a minimum of 16 dogs to be enrolled in the study for a period of 12 months at a cost of approximately
$150,000. However, the Company has the option to continue enrollment of dogs in the study to 24 or 32 dogs if it so chooses. The
cost of the study if the option to enroll 32 dogs is selected will be approximately $300,000. The Agreement is terminable upon
60-days written notice by either party
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
|
PETVIVO
HOLDINGS, INC.
|
|
|
Date:
November 11, 2020
|
By:
|
/s/
John Lai
|
|
Name:
|
John
Lai
|
|
Title:
|
Chief
Executive Officer
|
PetVivo (PK) (USOTC:PETV)
Historical Stock Chart
From Jun 2024 to Jul 2024
PetVivo (PK) (USOTC:PETV)
Historical Stock Chart
From Jul 2023 to Jul 2024